Check out our most popular compounded medications! Get Started
Bayview Pharmacy's Zinc Pyrithione 0.2%/Clobetasol Propionate 0.05% Topical Gel is a semisolid formulation dispensed through a pump mechanism. This design allows for easy and precise application on the skin, facilitating targeted treatment or absorption of active ingredients. It is used to treat various skin conditions such as Seborrheic Dermatitis, Psoriasis, Atopic Dermatitis, Lichen Planus, and Tinea Versicolor.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Bayview Pharmacy is pleased to present a specialized topical gel formulation of Zinc Pyrithione 0.2%/Clobetasol Propionate 0.05%. Zinc Pyrithione serves as an antifungal and antibacterial agent, aiding in the reduction of inflammation and itching. On the other hand, Clobetasol Propionate is a powerful corticosteroid that assists in minimizing redness and swelling.
This formulation is recommended for the treatment of various skin conditions, including psoriasis, eczema, seborrheic dermatitis, and contact dermatitis. The synergistic effect of the active ingredients helps to alleviate inflammation, itching, and redness associated with these conditions.
Our topical gel formulation is dispensed through a pump mechanism, facilitating easy and precise application on the skin for targeted treatment or absorption of active ingredients in a gel-like consistency. This makes it easy to apply and is generally well-tolerated by most patients. It is available in a convenient, easy-to-use tube and should be applied to the affected area twice daily. Patients are advised to use the product as directed and to avoid contact with the eyes and mucous membranes.
If you have any questions about this formulation or its application in treating skin conditions, please do not hesitate to contact us at Bayview Pharmacy. Our team of compounding pharmacists is here to assist you.
Zinc Pyrithione 0.2%/Clobetasol Propionate 0.05% Topical Gel is a specially compounded formulation designed for the treatment of mild to moderate plaque psoriasis, seborrheic dermatitis, and atopic dermatitis. This semisolid formulation is dispensed through a pump mechanism, allowing for easy and precise application on the skin. The gel-like consistency ensures targeted treatment and optimal absorption of the active ingredients.
It is crucial to note that this formulation is not recommended for the treatment of rosacea, acne, or perioral dermatitis. The topical gel should be applied to the affected area twice daily, or as directed by a healthcare provider. It is not recommended for use beyond a two-week period.
Patients should be aware of potential side effects, which may include skin irritation, burning, stinging, itching, redness, or dryness. If these side effects occur, it is advised to contact a healthcare provider. Additionally, this formulation may cause skin discoloration, particularly in areas of skin exposed to sunlight. Therefore, the use of sunscreen and protective clothing is recommended when using this formulation.
It is also important to note that this formulation may interact with other medications, including topical corticosteroids, antibiotics, antifungals, and other topical medications. Patients are advised to inform their healthcare provider of all medications they are currently taking before using this formulation.
If you have any questions or concerns about Zinc Pyrithione 0.2%/Clobetasol Propionate 0.05% Topical Gel, please do not hesitate to reach out for further information.
Zinc Pyrithione 0.2%/Clobetasol Propionate 0.05% Topical Gel is a compounded formulation designed to address various skin conditions such as psoriasis, eczema, and seborrheic dermatitis. This unique combination medication works by reducing inflammation and itching, while also inhibiting the growth of certain bacteria and fungi on the skin, providing targeted treatment for affected areas.
The active ingredients in this formulation are zinc pyrithione and clobetasol propionate. Zinc pyrithione serves as an antifungal and antibacterial agent, effectively reducing the growth of certain bacteria and fungi on the skin. On the other hand, clobetasol propionate is a potent corticosteroid that aids in reducing inflammation and itching, providing relief from discomfort.
This topical gel is dispensed through a pump mechanism, which facilitates easy and precise application on the skin. It is crucial to follow the instructions provided by your healthcare provider when using this medication. The medication should be applied evenly on the affected area, avoiding contact with the eyes, mouth, and other mucous membranes. It is also recommended to wash your hands thoroughly after applying the medication to prevent accidental spread to other areas.
Typically, this formulation is used twice daily or as directed by your healthcare provider. It is essential to complete the full course of treatment, even if symptoms improve, to ensure the condition is fully addressed and to prevent recurrence. If you have any questions or concerns about how to use this medication, it is advised to consult with your healthcare provider for further guidance.
This compounded formulation of Zinc Pyrithione 0.2%/Clobetasol Propionate 0.05% Topical Gel is a semisolid preparation designed for easy and precise application on the skin. The pump mechanism allows for targeted treatment, ensuring the active ingredients are absorbed effectively in a gel-like consistency. This formulation is versatile and can be used to treat a variety of skin conditions including contact dermatitis, eczema, and acne.
Not only does this formulation treat these conditions, but it also helps to reduce the inflammation and itching often associated with them. However, it is crucial to note that this formulation should not be applied on the face, groin, or axillae, as it may cause irritation. Furthermore, it is recommended that this formulation should not be used for a period exceeding two weeks, as prolonged use may lead to skin thinning and other potential adverse effects.
It is always important to use this formulation as directed by a healthcare professional and to reach out to a healthcare provider if you have any questions or concerns about its use. This formulation is a testament to the advancements in compounding pharmacy.
This is a compounded formulation of two active ingredients, Zinc Pyrithione and Clobetasol Propionate, in a gel-like consistency. It is designed for easy and precise application on the skin for targeted treatment.
The gel is dispensed through a pump mechanism, which allows for easy and accurate application on the skin.
The gel-like consistency facilitates absorption of the active ingredients into the skin, providing targeted treatment to the affected area.
The active ingredients in this topical gel are Zinc Pyrithione and Clobetasol Propionate.
Zinc Pyrithione is an antimicrobial agent that is commonly used to treat skin conditions such as dandruff and seborrheic dermatitis.
Clobetasol Propionate is a potent corticosteroid that is used to reduce inflammation and itching associated with various skin conditions.
You should apply this gel as directed by your healthcare provider. Typically, a thin layer of the gel is applied to the affected area of the skin.
This topical gel is intended for external use only. Avoid contact with eyes, mouth, and other mucous membranes. If you are unsure, consult with your healthcare provider.
If you experience any side effects such as redness, irritation, or worsening of your skin condition, stop using the product and contact your healthcare provider immediately.
If you are pregnant or breastfeeding, you should consult with your healthcare provider before using this product. The safety of this product for use during pregnancy or breastfeeding has not been fully established.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
The conditions listed on this page are indications prescribers have ordered this preparation for. They are not FDA-approved indications, and listing them is not a statement that this preparation is effective for them.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice — discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Apply topically to affected area(s)
